https://abio-x.com/ 2023-12-07T20:25:41+00:00 daily 1.0 https://abio-x.com/about/ 2023-11-16T00:19:47+00:00 daily 0.8 https://abio-x.com/companies/ 2024-08-15T04:18:59+00:00 daily 0.8 https://abio-x.com/news/ 2023-10-16T19:32:49+00:00 daily 0.8 https://abio-x.com/careers/ 2023-11-16T00:10:47+00:00 daily 0.8 https://abio-x.com/adcentrx-and-avantgen-enter-a-new-partnership-with-a-three-year-multi-target-collaboration-to-discover-antibodies-for-novel-antibody-drug-conjugates/ 2023-10-31T17:19:15+00:00 daily 0.8 https://abio-x.com/ensem-therapeutics-a-cbc-group-incubated-biopharma-company-raises-67-million-in-series-a-financing-to-develop-small-molecule-medicines-for-difficult-to-drug-targets/ 2026-07-12T00:30:29+00:00 daily 0.8 https://abio-x.com/adcentrx-therapeutics-announces-completion-of-50m-series-a-financing-led-by-cbc-group-to-accelerate-next-generation-conjugate-drugs-research-development/ 2023-10-31T17:57:37+00:00 daily 0.8 https://abio-x.com/adcentrx-therapeutics-announces-completion-of-38-million-series-a-financing-led-by-eight-roads-ventures/ 2023-10-20T22:40:55+00:00 daily 0.8 https://abio-x.com/sean-cao-phd-mba/ 2023-10-27T00:01:13+00:00 daily 0.8 https://abio-x.com/karly-jiayu-liu/ 2023-10-26T23:43:25+00:00 daily 0.8 https://abio-x.com/tianze-tao/ 2023-10-26T23:51:11+00:00 daily 0.8 https://abio-x.com/joanna-wu-phd-jd/ 2024-04-08T06:26:58+00:00 daily 0.8 https://abio-x.com/terry-ying/ 2023-11-01T22:52:06+00:00 daily 0.8 https://abio-x.com/karly-jiayu-liu-2/ 2023-11-01T16:33:49+00:00 daily 0.8 https://abio-x.com/terms-of-use/ 2023-11-15T18:16:04+00:00 daily 0.8 https://abio-x.com/francesca-solitro/ 2023-11-15T16:51:08+00:00 daily 0.8 https://abio-x.com/adcentrx-therapeutics-announces-first-patient-dosed-in-the-phase-1a-b-study-of-adrx-0706-a-novel-adc-targeting-nectin-4-for-the-treatment-of-advanced-solid-tumors/ 2023-10-31T00:42:54+00:00 daily 0.8 https://abio-x.com/adcentrx-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-for-adrx-0706-a-novel-adc-targeting-nectin-4-for-the-treatment-of-advanced-solid-tumors/ 2023-10-31T00:45:22+00:00 daily 0.8 https://abio-x.com/ensem-announces-the-promotion-of-shengfang-jin-phd-to-president-chief-executive-officer/ 2023-10-31T00:51:24+00:00 daily 0.8 https://abio-x.com/beigene-and-ensem-therapeutics-announce-partnership-to-advance-differentiated-cdk2-inhibitor/ 2023-11-21T17:43:35+00:00 daily 0.8 https://abio-x.com/sean-fu-phd-mba/ 2026-07-12T00:30:43+00:00 daily 0.8 https://abio-x.com/tracy-yeo-phd/ 2024-11-20T07:08:43+00:00 daily 0.8